Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track LNTH with free AI briefings, catalyst countdowns, and dilution alerts.

LNTH · Lantheus Holdings, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$593.3M Cash, Jun 2026

-4% Share Count, 1 Year

Follow LNTH by email Get an email when LNTH pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about LNTH, unsubscribe in one click. Privacy

📣 What LNTH Says Is Next

first half of 2027 · “The transaction is currently expected to close in the first half of 2027, subject to satisfaction of customary closing conditions, including receipt of Lantheus shareholder approval and required regulatory approvals.”
Company press release, Aug 3, 2026 · SEC filing
fourth quarter of 2026 · “Received FDA approval for PYLARIFY TruVu TM (piflufolastat F18), a new formulation of PYLARIFY ® , the Company’s market‑leading PSMA PET imaging agent, designed to enhance manufacturing efficiency and supply flexibility; a phased geographic commercial launch is planned to begin in the fourth quarter of 2026 to align with coding, coverage, payment, and customer and PMF readiness.”
Company press release, May 7, 2026 · SEC filing
fourth quarter of 2026 · “FDA approves PYLARIFY TruVu TM (piflufolastat F18); phased geographic launch planned to begin in the fourth quarter of 2026”
Company press release, May 7, 2026 · SEC filing

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

💰 Cash Runway & Dilution Risk

LNTH reported $593.3M in cash and short-term investments (as of Jun 30, 2026) and its operations are currently cash-flow neutral or positive.

Dilution pressure: 0 · Low

No operating cash burn in latest filings

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when LNTH files for a raise →

📅 Past FDA Decisions & Stock Reactions

Date	Drug	Type	Run-up 30d	Decision 1d	After 5d
2026-03-06	PYLARIFY TruVu	NDA	+15.6%	-4.9%	+5.4%

Browse all historical PDUFA outcomes →

Get the full LNTH picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for LNTH and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z